Skip to main content

Urinary Diversion–Specific Pharmacotherapy

Pharmacotherapy specific to patients with urinary diversion (ileal conduit, orthotopic neobladder, continent cutaneous reservoir, augmentation cystoplasty) — acid-base management, vitamin B12 supplementation, and mucus-production control. The shared theme: bowel-in-the-urinary-tract creates predictable physiologic perturbations that require lifelong surveillance and targeted pharmacologic management.

For diversion technique itself see Urinary Diversion Principles and the named-procedure pages.

  • Mucus ManagementIndividualized mechanical irrigation, obstruction warning signs, uncertain mucolytic benefit and small perioperative octreotide trials.
  • Vitamin B12 SupplementationAnatomic risk, annual surveillance after cystectomy with bowel diversion, and oral versus parenteral replacement according to cause, severity and response.
  • Urinary Acidifiers & AlkalinizersDistinguish systemic acidosis treatment, stone-specific urine-pH goals and methenamine activity; monitor kidney function, electrolytes and treatment response.